Ulcerative Colitis Clinical Trials in Chicago

Showing 321-340 of 699 trials

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

NCT02314156

This randomized trial studies transdermal or oral telapristone acetate in treating patients undergoing surgery to remove the breast (mastectomy). Telapristone acetate may help prevent breast cancer from forming in premenopausal women. Giving telapristone acetate transdermally may be safer and have fewer side effects than oral administration.

BRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma In Situ+6 more

Northwestern University67 participantsStarted Oct 2015

West Hollywood, California, United States • Chicago, Illinois, United States • New York, New York, United States

COMPLETED2.2 miles

Respiratory Infection Monitoring

NCT04362631

This study will monitor physical bio-markers such as heart rate, respiratory rate, and temperature to detect potential respiratory infections.

Chronic Obstructive Pulmonary Disease (COPD)

Northwestern University42 participantsStarted Apr 2020

Chicago, Illinois, United States

COMPLETEDPhase 22.2 miles

ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis

NCT00063414

This is a multi-center trial to test the safety, efficacy and tolerability of alicaforsen (ISIS 2302), a new type of drug called an antisense drug, in patients with mild to moderate active Ulcerative Colitis (UC). Alicaforsen is designed to reduce the production of a specific protein, called ICAM-1, a substance that plays a significant role in the increase of inflammation and is likely to be involved in inflammatory bowel diseases such as ulcerative colitis. The ISIS 2302-CS22 study will examine the effects of one of two dosages of alicaforsen delivered by enema over a six-week period as compared to an active control, mesalamine enema (The probability of receiving the alicaforsen formulation is 2:1). The primary objective of this study is to evaluate the percentage reduction in DAI at Week 6.

Ulcerative Colitis

Ionis Pharmaceuticals, Inc.Started Nov 2002

Chicago, Illinois, United States

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Respiratory Infection Monitoring

ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis

Ulcerative Colitis Trials in Other Cities

P200TE Agreement and Precision Study

Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma

Circadian Misalignment in Inflammatory Bowel Disease

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]

Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Inspire Home Study: Utilization of Home Monitoring During Therapy Optimization in Patients With an Inspire Upper Airway Stimulation System (Comparison of Home Sleep Testing vs. In-lab Polysomnography Testing)

Primary Tube Versus Trabeculectomy Study

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Improving Quality by Maintaining Accurate Problems in the EHR

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer

Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride

Other Conditions in Chicago